Skip to content

* Client Portal

* HIV & STI Testing

* PrEP & PEP

* Syringe Services

* Calendar

* Services & Communities

* Services

* Communities

* Connect

* QTPOC at Strut

* Get Involved

* Engage

* Support Our Work

* Partnerships

* Volunteer

* News & Events

* News

* Featured Topics

* Events

* Get The Latest

* Resources

* Sexual Health

* Harm Reduction

* Other Resources

* Living Positively

* About Us

* What We Do

* Our Team

* General information

* We’re hiring

__

Donate

One-Time Gift

Monthly Gift

* Services & Communities

* Services

* Sexual Health & Testing

* PrEP & PEP

* HIV Support

* Hepatitis C

* Substance Use Treatment * Counseling & Case Management * Syringe Access & Disposal * Overdose Prevention * Housing & Financial Benefits

* Support Groups

* Communities

* People Living With HIV * Queer & Trans People of Color * Gay, Bi & Queer Men

* African Americans

* Latinx

* Trans and Non-Binary People

* Women & Femmes

* People Over 50

* People Who Use Drugs & Alcohol * People Who Inject Drugs

* Connect

* Calendar

* Contact Us

* Locations & Hours

* Book an Appointment * Get Your Test Results

* Services Finder

* Our Programs

* QTPOC at Strut

QTPOC at Strut

Join us for an event for and by queer and trans people of color.

* Get Involved

* Engage

* Take Action

* Join a Group

* Volunteer

* Stonewall Clinical Internships * Sexual Health Clinical Training

* Careers

* Support Our Work

* Ways to Give

* AIDS/LifeCycle

* Dining Out For Life * Santa Skivvies Run * Tribute Celebration

* Partnerships

* Corporate

* Volunteer

Volunteer

Volunteers are at the heart of everything we do.

* News & Events

* News

* All Blogs

* Breaking News

* BETA Blog

* Status

* Featured Topics

* Sexual Health

* Harm Reduction

* HIV Prevention

* Events

* Calendar

* Fundraisers

* Event Guide

* Get The Latest

Get The Latest

Sign up for updates about programs and partnerships delivered right to

your inbox.

* Resources

* Sexual Health

* HIV FAQs

* HIV Risk and Testing

* HIV Prevention

* HIV Treatment

* U Equals U

* STIs

* Prevent HIV with PrEP

* PEP

* Harm Reduction

* What Is Harm Reduction?

* Drugs & Alcohol

* What is Hepatitis C?

* Safer Drug Use

* Safer Injection

* Meth & Speed

* Why Provide Syringes?

* Other Resources

* RESOURCE LIBRARY

* HIV & Hep C Statistics

* Our Research

* Living Positively

Living Positively

Info on HIV meds, sex & dating, disclosure and becoming undetectable

at your fingertips.

* About Us

* What We Do

* Our Mission

* Our Work

* Our Communities

* Our Programs

* Our Advocacy

* Our Impact

* Financial & Legal Documents

* Our Team

* Board of Directors

* Our Leadership

* Our Partners

* Careers

* VOLUNTEERS

* General information

* Contact Us

* Locations & Hours

* Media Inquiries

* Privacy Policy

* We’re hiring

We're hiring

Interested in joining our fight to end the epidemic? Find a great fit with us on the team.

* Client Portal

* HIV & STI Testing

* PrEP & PEP

* Syringe Services

* Calendar

Search __ X

BETA BLOG

Home / BETA Blog

Search by

Search Posts

Filter By Clear Filters

Author

* Brandyn Gallagher

* Charles Hawthorne

* Chris Hall, MD

* Cirrus Wood

* David Duran

* David Fawcett, PhD, LCSW

* Dolan Wolf

* Douchie

* Emily Land, MA

* Jason Wong, PT, DPT

* Jen Hecht, MPH

* Jennifer Cocohoba, PharmD * Jeremy Prillwitz, MA, CATC * Joanna Eveland, MD * Jonathan Van Nuys, RN, MS, NP

* Joshua O'Neal

* Kay Nilsson

* Liz Highleyman

* Loren Bruton

* Megan Canon, MPH

* Michael in Berlin

* Niko Kowell

* Pierre-Cédric Crouch, PhD, ANP-BC

* Reilly O'Neal

* Ryan Sallans

* San Francisco AIDS Foundation * Shaun Barcavage, NP * Shawn Demmons, MPH

* Tiommi Luckett

* Warren Tong

categories

* Advocacy

* Anal health

* Community

* Ending stigma

* Harm reduction

* Health policy

* Hepatitis C

* Living well

* Our impact

* Our partners

* Our voices

* PrEP

* Prevention

* Research

* Sexual health

* Substance use

* Testing

* Treatment

* U=U

* Uncategorized

Show Filters +

* Living well

* Research

FOR PEOPLE WITH HIV, CANNABIS USE LINKED TO LOWER RATES OF COGNITIVE

IMPAIRMENT

February 24, 2020

In a study with nearly 1,000 adults, cognitive functions such as verbal fluency, memory, attention and motor skills were significantly less likely to show signs of impairment in people living with HIV who

used cannabis.

* Harm reduction

* Our partners

HARM REDUCTION IS LOVE

February 11, 2020

Charles Hawthorne breaks down how the racist war on drugs stands in the way of health and humanity for drug users, and shares his perspective on reaching people with kindness, empathy and love.

* Advocacy

* Health policy

NUEVO INFORME REVELA LA CRISIS DE VIH EN LA COMUNIDAD LATINA NO

RECONOCIDA

February 4, 2020

En “grupos” de transmisión, la transmisión de VIH ocurre a tasas de hasta 33 veces el promedio nacional. Los programas de salud pública y del gobierno deben encontrar maneras de invertir en hacer llegar los servicios de

* Advocacy

* Health policy

UNRECOGNIZED HIV CRISIS IN LATINX COMMUNITY REVEALED BY NEW REPORT

February 4, 2020

In transmission “clusters”, HIV transmission occurs at rates up to 33 times the national average. Public health and government programs must find ways to invest in reaching Latinx communities with

HIV services.

* Treatment

STRONG WARNING AGAINST DOVATO 2-DRUG REGIMEN AS FIRST-LINE THERAPY BY SAN FRANCISCO HIV EXPERT

January 28, 2020

Concerns over drug resistance and adherence have a Ward 86 HIV clinician worried about the new HIV treatment guidelines by DHHS.

* Community

* Treatment

CONFRONTING THE CHALLENGE OF BRINGING HIV CARE TO PEOPLE

January 15, 2020

Street outreach services and drop-in clinics are reaching people experiencing homelessness living with HIV with services and care.

* Harm reduction

* Hepatitis C

IN SF, GAME-CHANGING PROGRAMS AIM TO CURE ALL OF HEPATITIS C

January 9, 2020

New programs in San Francisco are addressing the “silent epidemic” that affects more than 12,000 community members. HCV cure is possible, but many people don’t know it’s an option.

* PrEP

* Research

* Treatment

WHAT WE KNOW ABOUT DESCOVY’S IMPACT ON WEIGHT & CHOLESTEROL

January 8, 2020

HIV advocates have raised concerns about the metabolic effects that Descovy (F/TAF) may have on people living with HIV and people taking it for PrEP. Here’s what we know.

* Health policy

* Our partners

ENDING THE EPIDEMICS: CONVERSATION IN CALIFORNIA’S EAST BAY

December 16, 2019

Community members, community organizations, and health department officials from the San Francisco East Bay discussed the state of the HIV, hepatitis C and STI epidemics, and how to support the End the

Epidemics campaig

* Research

FIRST-OF-ITS-KIND COMBO HIV CURE STUDY TO BEGIN AT UCSF

December 11, 2019

A small number of participants will receive a combination of therapies designed to boost the immune system’s response to stimulate and clear the body’s HIV reservoir.

* Sexual health

* Testing

GOT AN STI? ANONYMOUSLY TELL SEX PARTNERS TO GET TESTED

November 18, 2019

Tell Your Partner, a free partner notification service, makes it easy to let people know they might need to get tested for STIs.

* Harm reduction

* Substance use

HARM REDUCTION AT THE HEART OF SF’S METH TASK FORCE RECOMMENDATIONS

November 1, 2019

Recently-released recommendations emphasize the need for compassionate, easy-to-access services for people who use meth in San

Francisco.

* Community

* Our voices

WE ASKED OUR COMMUNITY: WHAT DOES “LONG-TERM SURVIVOR” MEAN TO

YOU?

October 16, 2019

Community members who have lived through the early years of the HIV epidemic share their thoughts on if the term “long-term survivor” fits their experiences living with HIV or losing loved ones to HIV.

* PrEP

FDA APPROVES DESCOVY (F/TAF) FOR PREP

October 11, 2019

We now have a new medication for PrEP. Here's how Descovy (F/TAF) is different than Truvada (F/TDF).

* PrEP

TRUVADA LAWSUIT ADS ARE MISLEADING

October 9, 2019

Truvada is a well-studied medication that is safe for the vast majority of people taking it for PrEP and for HIV treatment.

* PrEP

* Research

34% OF TRANSMASCULINE PEOPLE GIVEN PREP INFO BY PROVIDERS

September 25, 2019

Transmasculine individuals need access to sexual health care and PrEP information, without assumptions or judgment about sexual preferences.

* Our impact

YEARLY HIV INFECTIONS IN SAN FRANCISCO DROP TO 197

September 13, 2019

In 2018, San Francisco reached a milestone in HIV prevention. Disparities are increasing for people of color, people experiencing homelessness and people who inject drugs.

* Research

* Treatment

WHAT DO PEOPLE THINK OF LONG-ACTING HIV MEDS?

August 15, 2019

Long-acting antiretrovirals may soon change the game for people living with HIV. New research explores the experiences of people receiving monthly injections for HIV treatment.

* Research

ISLATRAVIR: A POTENTIAL PREP & HIV DRUG NOW BEING TESTED

August 13, 2019

A new antiretroviral named islatravir is showing promise for HIV treatment, and for PrEP delivered through an under-the-skin implant.

* Our voices

TRANS FERTILITY IN CONVERSATION

August 2, 2019

There are many options for trans people interested in having a baby. Two reproductive health specialists answer questions that trans people may have about fertility, hormones and pregnancy.

* Research

* Treatment

IAS 2019 – LONG-ACTING HIV MEDICATIONS

July 29, 2019

Dr. Neal Sheran shares information about long-acting HIV medications currently being studied—including who might benefit from them, and some outstanding concerns from the medical community.

* Community

* Research

NEW DATA ON HIV INCIDENCE AMONG TRANS WOMEN IN SAN FRANCISCO

July 24, 2019

Erin Wilson, DrPH, MPH shares research conducted with trans women in San Francisco, and explains why simply providing accessible gender-affirming services and HIV prevention and care isn’t enough to offset inequities.

* PrEP

* Research

IAS 2019 – PREP USE BY TRANSMASCULINE & TRANSFEMININE FOLKS: NEW DATA FROM NORTHERN CALIFORNIA

July 24, 2019

In a sample of more than 2,500 transgender clients receiving care from a large managed health care system, only 16% with an indication for PrEP were linked to PrEP care.

* Research

* Substance use

ARTEMIS IMPROVES MOOD, REDUCES VIRAL LOAD FOR MEN USING METH

July 23, 2019

New research presented at IAS 2019 showed the effectiveness of a counseling intervention to improve mood, reduce substance use, and lower viral loads in men using meth. Showing posts 1 – 24 of 124

1 2 3

… 6

SIGN UP FOR OUR NEWSLETTER

__

WHO WE ARE

San Francisco AIDS Foundation is a California nonprofit public benefit corporation which has been granted tax exempt status under Internal Revenue Code section 501(c)(3). Our Federal EIN is 94-2927405 and our California corporation number is C1241510.

Donate

NAVIGATE

* Calendar

* Careers

* FINANCIALS

* Locations

* Contact Us

CONTACT

* info@sfaf.org

* 415-487-3000

*

* __

* __

* __

* __

* __

� 2020 San Francisco AIDS Foundation. All Rights Reserved

* Privacy Policy

* Disclaimer

Designed & Developed by Firefly Partners AddThis Sharing Sidebar Share to FacebookFacebookShare to TwitterTwitterShare to

LinkedInLinkedIn

Hide

Show

Close

AddThis

AddThis Sharing

FacebookTwitterLinkedIn This site uses cookies to improve your experience. If you continue browsing, you accept our use of cookies. You can review our privacy policy to find out more about

the cookies we use.

I Agree